摘要
器官移植受者由于长期服用免疫抑制药,是重型或危重型新型冠状病毒感染的高危人群,重症率和病死率高于普通人群。探讨器官移植受者新型冠状病毒感染诊治进展对提高患者救治水平有重要意义。因此,该文就器官移植受者新型冠状病毒感染的流行病学、临床特点、防治措施等方面作一综述。
Due to long-term use of immunosuppressive drugs,organ transplant recipients are at high risk of serious or critical coronavirus disease 2019(COVID-19),and their incidence rate of severe cases and mortality rate are higher than those of a general population.It is of great significance to explore the research progress in diagnosis and treatment of COVID-19 in organ transplant recipients for improving the rescue level of the patients.Therefore,this paper reviews the epidemiology,clinical characteristics,prevention and treatment measures of COVID-19 in organ transplant recipients.
作者
赖彦华
李甲志
杨建荣
LAI Yan-hua;LI Jia-zhi;YANG Jian-rong(Department of Transplantation,the People′s Hospital of Guangxi Zhuang Autonomous Region(Guangxi Academy of Medical Sciences),Nanning 530021,China)
出处
《中国临床新医学》
2023年第10期990-994,共5页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金
广西卫生健康委科研课题(编号:Z-A20230079)。
关键词
器官移植
新型冠状病毒
临床特点
疫苗
治疗
Organ transplantation
Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)
Clinical characteristics
Vaccine
Treatment